Rate Control Is a Better Initial Treatment for Patients With Atrial Fibrillation and Heart Failure : Rhythm Control vs. Rate Control : Which Is Better in the Management of Atrial Fibrillation? (Rate-Side)

スポンサーリンク

概要

• 論文の詳細を見る

• Congestive heart failure (CHF) and atrial fibrillation (AF) often coexist, and each increase the morbidity and mortality associated with the other. Until now, many studies have reported that a strategy of rate control, in combination with anticoagulation in patients at risk of thromboembolic events, appears to be at least equivalent to a strategy of maintaining sinus rhythm with currently available pharmacological therapeutic options. As compared to rhythm control therapy, rate control treatment is simple and relatively easy. Therefore, pharmacological rate control should be considered initially in patients with AF associated with CHF. However, cardiac symptoms associated with AF may continue after achieving reasonable ventricular rate control. Either pharmacological or non-pharmacological rhythm control needs to be considered at that time. Amiodarone is the only recommended antiarrhythmic drug in the recent therapeutic guidelines for CHF, and can be used for both rhythm and rate control of AF. However, there is no question that some patients require early non-pharmacological rhythm control instead of long-lasting rate control. Catheter ablation (CA) can be applicable even in AF associated with CHF, but the results of CA are closely associated with the clinical and electrophysiological characteristics in each patient, as well as with the experience with this procedure in each institution. Indications for and the appropriate period of CA need to be carefully examined in each individual. (Circ J 2011; 75: 970 - 978)

• 2011-03-25

著者

• Chinushi Masaomi

  School Of Health Science Niigata University School Of Medicine

• IIJIMA Kenichi

  First Department of Internal Medicine, Niigata University School of Medicine

• Iijima Kenichi

  First Department Of Internal Medicine Niigata University School Of Medicine

関連論文

• PJ-004 Clinical and ECG Characteristics as a Predictor of Recurrence of Ventricular Tachyarrhythmia (VTA) in Patients with Hypertrophic Cardiomyopathy (HCM)(PJ001,Arrhythmia, Others (Clinical/Pathophysiology) 1 (A),Poster Session (Japanese),The 73rd Annua
• Japanese Randomized Trial for Investigation of a Combined Therapy of Amiodarone and Implantable Cardioverter Defibrillator in Patients With Ventricular Tachycardia and Fibrillation : The Nippon ICD Plus Pharmacologic Option Necessity (NIPPON) Study Design
• Clinical Characteristics, Treatment, and Outcome of Tachycardia Induced Cardiomyopathy
• Primary Concerns during Daily Life in Patients with ICD and their Families (Role of ICD Discharge for Quality of Life)
• Comparison of triggering modes and therapeutic effect of nicorandil for ventricular tachyarrhythmia in canine models of LQT2 and LQT3
• Tridimensional analysis of onset mode and arrhythmogenesis of discordant QT/T alternans in long QT syndrome
• Significance of Early Onset and Progressive Increase of Activation Delay During Premature Stimulation in Brugada Syndrome
• PJ-692 Role of Faster Pacing and Magnesium (Mg) for the Treatment of Torsade de pointes (Tdp) Associated with Intravenous Amiodarone Administration(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scien
• PJ-688 The Abnormality of QT/RR Relationship in Brugada Syndrome and Idiopathic Ventricular Fibrillation without Prominent J-wave(PJ116,Ventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of T
• PJ-555 Distribution of Defibrillation Threshold (DFT) in Patients Treated with Implantable Cardioverter-Defibrillators (ICD) : Incidence and Characteristics of High DFT Patients(PJ093,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) 2 (A),Poster Sess
• PJ-089 Characteristics of the Subsequent Recurrence of Ventricular Tachyarrhythmia in Patients under ICD Therapy, Concern of Driving(PJ015,ICD (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PE-105 Exercise-induced QT Interval Prolongation and Its Relation to the Cardiac Events in Long QT Syndrome (LQTS) Carrying KCNQ1-Mutations(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting
• 4 Role of Antiarrhythmic Drugs in Preventing Sudden Cardiac Death(Fighting Cardiac Sudden Death: Efficacy and Future,Roundtable Discussion 8 (RT-8) (A),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• Preservation of Renal Function in Response to Cardiac Resynchronization Therapy
• PJ-789 Measurement of defibrillation threshold in the patients treated with implantable cardioverter-defibrillator (ICD)(Arrhythmia, therapy(22)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-694 Indication of ICD treatment as primary prevention of sudden cardiac death in Japanese patients with dilated cardiomyopathy(Heart failure, clinical(19)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Societ
• PJ-605 ECG characteristics of the time course of inappropriate ICD shocks due to T-wave double count(Arrhythmia, therapy(21)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-206 Relationship Between Electroanatomical Mapping Characteristics and Optimal Ablation Site in Idiopathic Ventricular Arrhythmia Originated Right Ventricular Outflow Tract Septum(Arrhythmia,diagnosis/Pathophysiology/EPS(13)(A),Poster Session(Japanese)
• OJ-150 Antiarrhythmic Effects of Bepridil to Ventricular Tachyarrhythmias : Focus on the Transmural Dispersion of Repolarization and Sympathetic Nerve Activity(Arrhythmia, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Comparison of Efficacy of Sotalol and Nifekalant for Ventricular Tachyarrhythmias(CLINICAL INVESTIGATION)
• Segmental Conduction Block in a Low-Voltage Area Suppressed Macro-Reentrant Ventricular Tachycardia after Surgical Repair of Tetralogy of Fallot
• Decrease in Amplitude of Intracardiac Ventricular Electrogram and Inappropriate Therapy in Patients With an Implantable Cardioverter Defibrillator
• PJ-294 Shortening of QT Interval by Mexiletine and It's Clinical Use in LQTl and LQT2(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-097 Intracoronary Acetylcholine (Ach) Induces a Greater QT Interval Prolongation and Torsade de Points (TdP) in LQT2 Than LQT1(Autonomic nervous system-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-494 Role of Sympathetic Nerve Activity and Therapeutic Effect of Beta-blockers for Polymorphic Ventricular Tachycardia (PVT) in a Canine LQT3 Model(Autonomic nervous system-5 (H) PJ83,Poster Session (Japanese),The 70th Anniversary Annual Scientific Mee
• PE-135 Clinical Characteristics and Outcome of Ventricular Tachyarrhythmia Associated with Sarcoidosis : Comparison with Ischemic Heart Disease(Arrhythmia, diagnosis/pathophysiology/EPS-8 (A) PE23,Poster Session (English),The 70th Anniversary Annual Scien
• OJ-376 Incidence and Initial Pattern of Pilsicainide Induced Polymorphic Ventricular Tachycardia (PVT) in Patients with Brugada-like ECG Abnormality(ECG/Body surface potential mapping/Holter-3 (A) OJ63,Oral Presentation (Japanese),The 70th Anniversary Ann
• OJ-375 STJ Normalization by Quinidine was Associated with QT Prolongation in Precordial Lead Due to Restoration of the Phase 2 Dome(ECG/Body surface potential mapping/Holter-3 (A) OJ63,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Me
• Efficacy of Bepridil for Antiarrhythmic Drug Refractory Ventricular Tachyarrhythmias in ICD Patients with Structural Heart Disease(Arrhythmia, Pharmacological Therapy 4 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Incidence and Predictors of Atrial Fibrillation in Subjects without Structural Heart Disease(Preventive Medicine/Epidemiology/Education/Health Policy 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• PE-109 The Results of Electrophysiological Study for Nifekalant can Predict the Efficacy of Chronic Sotalol Treatment in Patients with Ventricular Tachyarrhythmia.(Arrhythmia, Pharmacological Therapy 1 (A) : PE19)(Poster Session (English))
• OJ-429 Antiarrhythmic effects of magnesium sulfate for ventricular tachyarrhythmia developed under the condition of QT interval prolongation(ECG/Body Surface Potential Mapping/Holter 6 (A) : OJ52)(Oral Presentation (Japanese))
• OJ-234 Possibility and Problems to resume driving in patients with Implantable-Cardioverter Defibrillator (ICD) : Estimated risk of future ICD therapy(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese))
• Amiodarone Therapy in Patients Implanted With Cardioverter-Defibrillator for Life-Threatening Ventricular Arrhythmias
• Effect of Bepridil in Atrial Fibrillation Inducibility Facilitated by Vagal Nerve Stimulation : Prevention of Vagal Nerve Activation-Induced Shortening of the Atrial Action Potential Duration
• Efficacy of Procainamide and Lidocaine in Terminating Sustained Monomorphic Ventricular Tachycardia : Retrospective Case Series
• PJ-201 A Compound Heterozygous Mutation in KCNQ1 Associated with Long QT Syndrome(Arrhythmia, basic(05)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Correlation Between the Effective Refractory Period and Activation-Recovery Interval Calculated From the Intracardiac Unipolar Electrogram of Humans With and Without dl-Sotalol Treatment
• OE-334 Electrocardiographic Effects of Quinidine in Brugada Syndrome : Is It Beneficial or Not?(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
• OE-329 Ventricular tachyarrhytmia developed during treatment with class III antiarrhythmic drugs : arrhythmogenesis of slow heart rate and sympathetic nerve activity(Arrhythmia, Pharmacological Therapy 4 (A): OE42)(Oral Presentation (English))
• OE-139 Impact of Incessant Earthquake on Sudden Death, Acute Coronary Syndrome, Takotsubo Cardiomyopathy, and Pulmonary Embolism : the Niigata Chuetsu Earthquake Study(Preventive medicine/Epidemiology/Education-1 (H) OE24,Oral Presentation (English),The 7
• PJ-049 A Comparison of Dilated Cardiomyopathy with Hypertrophic Cardiomyopathy in Efficacy of Implantable Cardioverter-Defibrillator(Arrhythmia, therapy-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PE-022 Investigation of Activation Delay After Premature Stimulation in Brugada Syndrome(Arrhythmia, diagnosis/pathophysiology/EPS-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-207 Ca-antagonist Therapy in Brugada Syndrome Patients(Arrhythmia, diagnosis/pathophysiology/EPS-04, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-055 Poor Adaptation of QT Interval and Characteristics of Electrocardiographic Parameters of Repolarization in Brugada Syndrome(ECG/Body surface potential mapping/Holter-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• 2 Possible Candidate of CRT-D Treatment : From the Analysis of ICD and CRT-P Patients(Indication for CRT-D, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Non-Pharmacological Management of Ventricular Tachycardia(Ventricular Tachycardia/Fibrillation)
• Metabolic Syndrome and Catheter Ablation in Atrial Fibrillation
• Clinical characteristics of patients with inappropriate implantable cardioverter defibrillator(ICD)therapies : indication for dual-chamber ICD for sinus tachycardia
• Incidence and clinical implications of visible T-wave alternans in Brugada syndrome
• Intramural Arrhythmogenesis of ECG Phenomenon of Prolonged QT Interval, Short-Long Cardiac Cycle and T Wave Alternans in Long QT Syndrome
• Arrhythmogenesis of Sympathetic Activity Related Ventricular Tachyarrhythmias in Type 3 Long QT Syndrome (LQT3)
• Inappropriate Pacing Inhibition Triggered by QT Prolongation due to T Wave Oversensing in an ICD Recipient Presenting with Long QT Syndrome
• Ventricular Tachyarrhythmias in a Canine Model of LQT3 Arrhythmogenic Effects of Sympathetic Activity
• Rate Control Is a Better Initial Treatment for Patients With Atrial Fibrillation and Heart Failure : Rhythm Control vs. Rate Control : Which Is Better in the Management of Atrial Fibrillation? (Rate-Side)
• Correlation Between the Effective Refractory Period and Activation-Recovery Interval Calculated From the Intracardiac Unipolar Electrogram of Humans With and Without dl-Sotalol Treatment
• Endocardial Arrhythmogenic Mechanisms of Torsades de Pointes in Patients with the Congenital Long QT Syndrome
• An Appropriate Defibrillation Threshold Obtained by the Combined Connection Between Two Shock Leads and ICD Generator
• Effect of Bepridil in Atrial Fibrillation Inducibility Facilitated by Vagal Nerve Stimulation : – Prevention of Vagal Nerve Activation-Induced Shortening of the Atrial Action Potential Duration –
• Delayed Pericardial Effusion Due to Perforation of the Right Ventricular Outflow Tract by an ICD Lead
• Guidelines for Risks and Prevention of Sudden Cardiac Death (JCS 2010) : Digest Version
• An Appropriate Defibrillation Threshold Obtained by the Combined Connection between Two Shock Leads and ICD Generator
• Insulation Defects in Riata Implantable Cardioverter-defibrillator Leads
• Magnesium Treatment for Drug-Induced QT Prolongation
• Long QT Syndrome with Nocturnal Cardiac Events Caused by a KCNH2 Missense Mutation (G604S)
• Impact of Mid-Niigata Prefecture Earthquake on Cardiovascular Diseases
• Benign Premature Ventricular Complexes from the Right Ventricular Outflow Tract Triggered Polymorphic Ventricular Tachycardia in a Latent Type 2 LQTS Patient
• The Effectiveness of Nifekalant Hydrocholoride for Treatment of Refractory Ventricular Arrhythmia
• Correlation between Surface and Intracardiac Electrocardiogram in a Patient with Inappropriate Defibrillation Shocks Due to Hyperkalemia

もっと見る 閉じる

スポンサーリンク